Biopharmaceutical Third-Party Logistics Market Report 2026

Biopharmaceutical Third-Party Logistics Market Overview

• Biopharmaceutical Third-Party Logistics market size has reached to $150.5 billion in 2025 • Expected to grow to $221.15 billion in 2030 at a compound annual growth rate (CAGR) of 8.1% • Growth Driver: Outsourcing Logistics Drives Growth In Biopharmaceutical 3Pl Market • Market Trend: Companies Are Expanding Logistics Capabilities For Efficient Healthcare Product Management • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Biopharmaceutical Third-Party Logistics Market?

Biopharmaceutical third-party logistics refers to a partner or service that helps in the provision of logistics services by external entities to pharmaceutical companies. These companies delegate their transportation needs to third-party providers to minimize costs, and the absence of in-house capabilities is a significant factor driving the expansion of transportation outsourcing. The main types of biopharmaceutical third-party logistics supply chains are cold chain and non-cold chain. The cold chain refers to a supply chain that maintains temperature control throughout the transportation of temperature-sensitive products. the various services are transportation, warehousing and storage, and others used by pharmaceutical and biopharmaceutical companies, medical device companies, hospitals and clinics, and others.

What Is The Biopharmaceutical Third-Party Logistics Market Growth Forecast?

The biopharmaceutical third-party logistics market size is expected to see strong growth in the next few years. It will grow to $221.15 billion in 2030 at a compound annual growth rate (CAGR) of 8.1%. The growth in the forecast period can be attributed to increasing demand for personalized medicines, expansion of cell and gene therapy distribution, rising investments in smart logistics platforms, growing focus on end-to-end supply chain visibility, increasing cross-border biopharmaceutical trade. Major trends in the forecast period include increasing adoption of advanced cold chain logistics solutions, rising demand for temperature-monitored transportation services, growing use of real-time shipment tracking platforms, expansion of specialized biopharma warehousing infrastructure, enhanced focus on regulatory-compliant logistics operations.

Global Biopharmaceutical Third-Party Logistics Market Segmentation

1) By Supply Chain: Cold Chain, Non-Cold Chain 2) By Service: Transportation, Warehousing And Storage, Other Services 3) By End-User: Pharmaceutical And Biopharmaceutical Companies, Medical Device Companies, Hospitals And Clinics, Other End-Users Subsegments: 1) By Cold Chain: Refrigerated Transport, Temperature-Controlled Storage, Specialized Packaging 2) By Non-Cold Chain: Ambient Transport, Standard Storage Solutions, General Packaging Methods

What Is The Driver Of The Biopharmaceutical Third-Party Logistics Market?

The rising trend of outsourcing logistics is expected to drive the growth of the biopharmaceutical third-party logistics market. Outsourcing logistics involves engaging a third party to handle all or a portion of a company's logistical activities. Outsourcing logistics is used in biopharmaceutical third-party logistics for outsourcing cryogenic supply chain management to logistics partners. For instance, in February 2024, according to the Bureau of Transportation Statistics, a US-based part of the Department of Transportation (DOT), for-hire freight shipments rose by 1.8% in December 2023 compared to December 2022, while the Freight Transportation Services Index increased from 136.6 in December 2022 to 139.1 in December 2023. Therefore, the rising trend of outsourcing logistics is expected to propel the growth of the biopharmaceutical third-party logistics industry.

Key Players In The Global Biopharmaceutical Third-Party Logistics Market

Major companies operating in the biopharmaceutical third-party logistics market are McKesson Corporation, AmerisourceBergen Corporation, United Parcel Service of America Inc., FedEx Corporation, DHL International GmbH, Kuehne + Nagel International AG, SF Express Co Ltd., DB Schenker, CH Robinson Worldwide Inc., Nippon Express Group, Expeditors International of Washington Inc., Sinotrans Limited, XPO Logistics Inc., Kerry Logistics Network Limited, Bollore Logistics, VersaCold Logistics Services, Cryoport Inc., Agility Logistics Corp, Fisher Clinical Services, CEVA Logistics Inc., LifeScience Logistics, Cold Chain Technologies LLC, Langham Logistics, Airpharm Logistics, Express Courier International, Bio Pharma Logistics

Global Biopharmaceutical Third-Party Logistics Market Trends and Insights

Major companies operating in the biopharmaceutical third-party logistics market are focusing on innovative solutions such as business expansion in life sciences and healthcare logistics to enhance logistics capabilities for pharmaceutical and healthcare products, ensuring efficient storage and distribution. Business expansion in life sciences and healthcare logistics refers to the strategic growth of logistics companies to enhance their capabilities in transporting and managing medical products, which is crucial for ensuring timely delivery and maintaining the integrity of temperature-sensitive items essential for patient care. For instance, in May 2025, DHL Group, a Germany-based logistics company, announced the grand opening of its upgraded Life Sciences & Healthcare (LSH) campus in Florstadt, Germany. The new facility includes ultra cold storage zones (down to –70°C), real-time visibility systems, and GDP certified infrastructure, enabling secure handling of temperature-sensitive biopharmaceuticals, including mRNA vaccines, clinical trial materials, and advanced therapies.

What Are Latest Mergers And Acquisitions In The Biopharmaceutical Third-Party Logistics Market?

In March 2025, DHL Group, a Germany based logistics and supply chain provider, acquired CryoPDP from Cryoport for an undisclosed amount. With this acquisition, DHL aims to expand its temperature-sensitive logistics capacity, particularly for the life sciences and healthcare sector, and strengthen its ability to serve clients in clinical development and advanced therapy supply chains. CryoPDP is a France-based company offering white-glove, cold-chain courier services specialized in biopharma, with deep expertise in managing GDP compliant transportation of temperature-sensitive and complex pharmaceutical products.

Regional Outlook

North America was the largest region in the biopharmaceutical third party logistics market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Biopharmaceutical Third-Party Logistics Market?

The biopharmaceutical third-party logistics market consists of revenues earned by entities by providing biopharmaceutical third-party logistics such as domestic transportation management, international transportation management, and value-added warehousing and distribution. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Biopharmaceutical Third-Party Logistics Market Report 2026?

The biopharmaceutical third-party logistics market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the biopharmaceutical third-party logistics industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.